Correlates of left atrial size in hypertensive patients with left ventricular hypertrophy: the Losartan Intervention For Endpoint Reduction in Hypertension (LIFE) Study.
about
Novel Electrocardiographic Patterns for the Prediction of Hypertensive Disorders of Pregnancy--From Pathophysiology to Practical ImplicationsEpidemiology of left ventricular hypertrophy in hypertension: implications for the clinic.Influence of age on the relationship between left atrial performance and left ventricular systolic and diastolic function in systemic arterial hypertension.Accuracy of electrocardiographic criteria for atrial enlargement: validation with cardiovascular magnetic resonanceEffect of renal denervation on left ventricular mass and function in patients with resistant hypertension: data from a multi-centre cardiovascular magnetic resonance imaging trial.Atrial Fibrillation Complicating Congestive Heart Failure: Electrophysiological Aspects And Its Deleterious Effect On Cardiac Resynchronization TherapyLongitudinal tracking of left atrial diameter over the adult life course: Clinical correlates in the community.P wave area for quantitative electrocardiographic assessment of left atrial remodeling.The three integrated phases of left atrial macrophysiology and their interactions.Association of left atrial endothelin-1 with atrial rhythm, size, and fibrosis in patients with structural heart disease.The left atrium, atrial fibrillation, and the risk of stroke in hypertensive patients with left ventricular hypertrophy.Body weight and risk of atrial fibrillation in 7,169 patients with newly diagnosed type 2 diabetes; an observational study.Implications of the LIFE trial.Association of cardiorespiratory fitness with left ventricular remodeling and diastolic function: the Cooper Center Longitudinal StudyAtrial Remodeling in Pregnant Hypertensive Women: Comparison between Chronic and Gestational Hypertension.Determinants of Left Atrial Volume in Patients with Atrial Fibrillation.Left atrial structure and function and clinical outcomes in the general population.Relations of circulating resistin and adiponectin and cardiac structure and function: the Framingham Offspring Study.Cardioprotective effects of lysyl oxidase inhibition against volume overload-induced extracellular matrix remodeling.Catheter Ablation of Atrial Fibrillation in Overweight and Obese Patients.Structural and Functional Remodeling of the Left Atrium: Clinical and Therapeutic Implications for Atrial Fibrillation.Oxidative stress in renal dysfunction: mechanisms, clinical sequelae and therapeutic options.Prevalence of echocardiographic left-atrial enlargement in hypertension: a systematic review of recent clinical studies.Effect of telmisartan on atrial fibrillation recurrences in patients with hypertension: a systematic review and meta-analysis.Association of left atrial enlargement with ventricular remodeling in hypertensive Chinese elderly.Left atrium: the last bulwark before overt heart failure.Left atrial enlargement and right ventricular hypertrophy in essential hypertension.Relationship between abnormal P-wave terminal force in lead V1 and left ventricular diastolic dysfunction in hypertensive patients: the LIFE study.Left atrial volume index as a marker of left ventricular diastolic dysfunction in asymptomatic Tanzanian diabetic patients.Left atrial dimension and risk of stroke in women without atrial fibrillation: the Chin-Shan Community Cardiovascular Cohort study.Correlation between supra-sternal Doppler cardiac output (USCOM) measurements and chest radiological features.Prevalence and correlates of echocardiographic left atrial enlargement in hypertensive outpatients in clinical practice.Influence of regression of left ventricular hypertrophy on left atrial size and function in patients with moderate hypertension.The influence of insulin resistance and obesity on left atrial size in Japanese hypertensive patients.Left ventricular mass but not geometry determines left atrial size in the early stages of hypertension.Arterial-atrial coupling in untreated hypertension.Left atrial anatomy and function after conversion from atrial fibrillation in hypertrophic hearts.Age is not a predictor of patent foramen ovale with right-to-left shunt in patients with cerebral ischemic events.Electrocardiographic detection of hypertensive left atrial enlargement in the presence of obesity: re-calibration against cardiac magnetic resonance.Left atrial enlargement: a prevalent marker of hypertensive heart disease.
P2860
Q26799339-BEC81723-6E39-423D-8260-ACF71C1C82EDQ30250365-4DCD7917-33F5-4D15-ADB0-7433BECCAE9CQ30493970-4A76910B-49FD-4228-8FC9-19CBCA9AA68BQ30496864-353E53EF-5BC4-4A91-8281-7B12A18546EAQ30772422-766EDDDF-41D3-4151-BBC7-EAE30E91DF6FQ33585671-84C432D5-64C3-46AD-979A-586E564F9140Q33659377-17D6BF5D-C2B8-47AA-A3B2-F446BB667A77Q33717257-3A65D3D5-64FA-4FDC-AED9-C05962B6D95DQ34358906-872A6173-4D17-4B3D-881E-FE26666066B5Q34630156-F8BD2575-A366-4231-B0E8-238262864AF2Q34915626-EFCF3604-C79A-4E6C-AA89-29D3DC819B76Q34985247-CE3D7923-0C10-42E8-B574-728F18367B45Q35117105-FBD26729-8DBD-43A5-A8E9-9AA7A8B4EA6CQ35634804-EF058704-12D0-4802-AE39-F263B9CEDE84Q35800669-28A1595D-011C-4B98-BA71-EF694628A239Q36152831-676A9A64-7F61-4C7D-A5EE-4E25E2BD426FQ36547084-5F79FA8D-F8E8-4F8B-8066-D4EFC1860FE1Q37026291-FB955B28-340D-417A-B19A-B0128C67DFECQ37107505-A82E1F51-9742-4CF4-96EF-9951A1BD6213Q37495903-AB108B0C-7A6B-41F2-BF42-98681D7A4405Q37496071-4389CE81-E653-4F1A-987B-FB495BAF4BF9Q37591164-B3227E79-CA28-492F-8B04-7CA812C8D6CBQ38079711-C0A1E4E2-1F8F-4F39-BABB-3B21F50F946EQ38197227-484E2ECF-5070-4298-86B4-333415775326Q38936247-563B5668-52AD-4ABE-AF0A-D8CFFB3A575EQ39016287-A278AAB7-18FF-4FB3-9438-0DC0A815C720Q39402966-7F457FE1-C8F9-4BAF-8175-4305B92FB088Q39416674-516B8974-6E33-4D6B-8C85-942022ED94B7Q43938567-D25E4EDC-F778-4D09-9662-09FD5034B2C3Q44633803-A4445419-B6E4-4E9A-8C17-320E5E2DF2C9Q46006846-A5C759B1-6138-47B6-87C4-7E3EF25CBB47Q46019423-3AEA0D1F-FF34-4AA4-AC8E-22AE497B5E40Q46781548-6998FD52-0F15-472F-8261-64B335BCA5B6Q47187829-5A826C1D-F2E0-463A-86CD-8709EAC5658BQ47193339-43E8E1E3-6AA9-42C5-B031-E2DFD4CE644AQ48691848-E708065E-4B7C-442E-AC70-2664D0B05FD1Q50774922-80174C37-509F-4CDC-88AA-151316692BE7Q51992349-2C5A0EC7-651C-4D70-BF16-FE4E864511F2Q53032600-300688C6-3739-40D9-B3E0-5F642F6656B7Q54485627-2A891CFF-E9D9-4637-B5A2-A0CF0F202CDE
P2860
Correlates of left atrial size in hypertensive patients with left ventricular hypertrophy: the Losartan Intervention For Endpoint Reduction in Hypertension (LIFE) Study.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Correlates of left atrial size ...... in Hypertension (LIFE) Study.
@en
Correlates of left atrial size ...... oint Reduction in Hypertension
@nl
type
label
Correlates of left atrial size ...... in Hypertension (LIFE) Study.
@en
Correlates of left atrial size ...... oint Reduction in Hypertension
@nl
prefLabel
Correlates of left atrial size ...... in Hypertension (LIFE) Study.
@en
Correlates of left atrial size ...... oint Reduction in Hypertension
@nl
P2093
P50
P356
P1433
P1476
Correlates of left atrial size ...... in Hypertension (LIFE) Study.
@en
P2093
Eva Gerdts
Jan Erik Otterstad
Kristian Wachtell
Kurt Boman
Lasse Oikarinen
Losartan Intervention For Endpoint Reduction in Hypertension (LIFE) Study
P304
P356
10.1161/HY0302.105683
P407
P577
2002-03-01T00:00:00Z